Drug Delivery

Women in pharma face unique obstacles: Shorla Pharma

16-Sep-2020 By Jenni Spinner

A cofounder of the Irish pharmaceutical firm will join others in sharing her perspective as a female pharmaceutical leader at this year’s CPhI event.

IntelGenx, ATAI partner on film-based psychedelics

03-Sep-2020 By Jenni Spinner

The companies will join forces to use IntelGenx’s polymeric film technologies for development of pharmaceutical-grade psychedelic drug treatments.

Thermo Fisher expands cryo-EM access

31-Aug-2020 By Jenni Spinner

The company intends to enable pharma and biotech companies to have greater access to cryo-electronic microscopy for their research projects.

TFF, Union Therapeutics join on potential COVID-19 treatment

27-Aug-2020 By Jenni Spinner

The companies will partner on developing dry-powder forms of niclosamide as a treatment for the virus, using thin-film freezing technology.

Colorcon invests in AI-centric drug discovery

24-Aug-2020 By Jenni Spinner

The pharmaceutical technology investment fund is partnering with and financing Atomwise, a company that provides AI solutions for drug discovery

Healx collaborates on Angelman syndrome therapies

19-Aug-2020 By Jenni Spinner

The AI-centric drug discovery technology firm is working with a foundation to discover potential treatments for the rare neurogenetic disorder.

People on the Move: August 2020

04-Aug-2020 By Jenni Spinner

This month's spotlight on new hires, promotions and company acquisitions involves Elligo Health Research, PPD, Pfizer, Covance and other industry firms.

Research partnership delves into opioid alternatives

03-Aug-2020 By Jenni Spinner

Neurasic Therapeutics is borne from a collaborative effort intended to advance development of opioid-alternative pain relief.

Most recent FDA COVID-19 updates

30-Jul-2020 By Jenni Spinner

The US agency continues to put out informational resources, issue EUAs for tests and treatments, and monitor industry activity related to the virus.

Lonza: the right bio model can make a difference

27-Jul-2020 By Jenni Spinner

A leader from the health solutions and technology company explains how the proper biological models can enhance drug discovery and development.

Novartis launches NFP portfolio of COVID-19 treatments

21-Jul-2020 By Jenni Spinner

The company’s Sandoz division is offering 15 generic and OTC medicines to be sold at zero profit to low- and middle-income countries to treat the virus.

Aigenpulse launches AI-based discovery platform

20-Jul-2020 By Jenni Spinner

The company is introducing technology using artificial intelligence and machine learning to accelerate drug discovery and development.

Syneos Health inks service deal with Pfizer

16-Jul-2020 By Jenni Spinner

The clinical development and consulting firm has signed a three-year service agreement to support the pharma firm with development service solutions.

Indegene: AI is transforming the pharma industry

14-Jul-2020 By Jenni Spinner

A leader from the healthcare solutions firm shares perspective on how application of advanced technologies has driven the evolution of the entire industry.